Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans.
Proteasomes are cellular complexes that break down proteins. In some cancers ...
The Official Website for VELCADE® (bortezomib). ... VELCADE (bortezomib) is
approved for the treatment of people with multiple myeloma (a cancer of the ...
Jan 6, 2017 ... Easy to read patient leaflet for bortezomib. Includes indications, proper use,
special instructions, precautions, and possible side effects.
May 1, 2010 ... Bortezomib is used to treat people with multiple myeloma (a type of cancer of the
bone marrow) who have already been treated with at least ...
The boron atom within bortezomib catalytically binds the active site of the 26S
proteasome with high affinity and specificity, thereby resulting in cell cycle arrest
Find patient medical information for bortezomib injection on WebMD including its
uses, side effects and safety, interactions, pictures, warnings and user ratings.
(bore TEZ oh mib). Trade name: Velcade<sup>®</sup>. Chemocare.com uses generic names
in all descriptions of drugs. Velcade is the trade name for Bortezomib. In some ...
Oct 9, 2015 ... VELCADE® for Injection contains bortezomib which is an antineoplastic agent.
Bortezomib is a modified dipeptidyl boronic acid. The chemical ...
Feb 12, 2014 ... The biological therapy drug bortezomib (Velcade) is a treatment for myeloma.
The possible side effects include feeling or being sick; tiredness; ...
Bortezomib reversibly inhibits the 26S proteasome, a large protease complex that
degrades ubiquinated proteins. By blocking the targeted proteolysis normally ...